Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Assembly Biosciences (ASMB) EPS (Weighted Average and Diluted) (2019 - 2025)

Historic EPS (Weighted Average and Diluted) for Assembly Biosciences (ASMB) over the last 6 years, with Q3 2025 value amounting to -$0.72.

  • Assembly Biosciences' EPS (Weighted Average and Diluted) rose 5231.79% to -$0.72 in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.79, marking a year-over-year increase of 3078.03%. This contributed to the annual value of -$6.69 for FY2024, which is 4999.19% up from last year.
  • As of Q3 2025, Assembly Biosciences' EPS (Weighted Average and Diluted) stood at -$0.72, which was up 5231.79% from -$1.33 recorded in Q2 2025.
  • In the past 5 years, Assembly Biosciences' EPS (Weighted Average and Diluted) registered a high of -$0.41 during Q3 2021, and its lowest value of -$4.46 during Q1 2023.
  • Moreover, its 4-year median value for EPS (Weighted Average and Diluted) was -$1.58 (2024), whereas its average is -$1.84.
  • Its EPS (Weighted Average and Diluted) has fluctuated over the past 5 years, first plummeted by 38963.39% in 2021, then surged by 6278.03% in 2024.
  • Over the past 4 years, Assembly Biosciences' EPS (Weighted Average and Diluted) (Quarter) stood at -$1.37 in 2021, then fell by 29.2% to -$1.77 in 2023, then rose by 2.76% to -$1.72 in 2024, then skyrocketed by 58.17% to -$0.72 in 2025.
  • Its last three reported values are -$0.72 in Q3 2025, -$1.33 for Q2 2025, and -$1.17 during Q1 2025.